Clinical Trial Update: REM (Risk Of Endometrial Malignancy) [NA]

View source ↗

Summary

The REM trial (Risk Of Endometrial Malignancy) has completed, sponsored by Campus Bio-Medico University; the update does not provide results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Campus Bio-Medico University | Conditions: Endometrial Disease | NA | Status: COMPLETED